Rafarma Pharmaceuticals, Inc. RAFA OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

51/100

3/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Rafarma Pharmaceuticals, Inc. (RAFA) 当前追踪市盈率 (P/E) 为 21.7. 追踪盈利收益率为 4.61%.

本页证实的标准:

VALUE (75/100, 通过) — 市盈率低于市场平均水平 (21.7); 盈利收益率超过债券收益率 (4.61%).
追踪盈利收益率 4.61% — 与债券收益率（约4.3%）大致持平，风险回报适中。

SharesGrow 综合评分： 49/100 其中 3/7 项标准通过。

SharesGrow 7-Criteria Score

51/100

SG Score

View full scorecard →

✓

价值

75/100

Price-to-Earnings & upside

Proven by this page

—

未來

N/A

No coverage

✓

过去

100/100

→ Income

✓

健康

83/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

0/100

→ Income

✗

成长

15/100

→ Income

✗

收入

30/100

→ Income

估值概览 — RAFA

估值倍数

P/E (TTM)21.7

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.63

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.10

每股自由现金流$0.00

收益率与内在价值

盈利收益率4.61%

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$0.00	$0.00	$0.00	-
2014	$0.00	$0.00	$-14.85K	-
2017	$0.00	$125.1K	$-97.07K	-77.6%
2018	$0.00	$147.2K	$-6.18K	-4.2%
2019	$0.03	$11.44M	$3.05M	26.7%
2020	$0.17	$74.73M	$14.85M	19.9%
2021	$0.13	$77.41M	$11.57M	15%
2022	$0.06	$64.31M	$4.96M	7.7%
2023	$0.00	$10.14M	$273K	2.7%
2024	$0.00	$9.08M	$266K	2.9%